Sign Out
Hypersensitivity to the active substance or to any of the excipients listed in Description.
Cardiovascular disease grade 3 with a negative benefit/risk assessment or grade 4 (South West Oncology Group criteria).
Moderate or severe renal insufficiency (creatinine clearance <50 ml/min).
Moderate or severe hepatic insufficiency.
Continue with Google